The U.S. government has contracted with companies like North Carolina-based GlaxoSmithKline, which is getting $2.8 million to produce 84,300 treatment courses of the antiviral drug Relenza (zanamivir).
Guess its a start
http://www.foxnews.com/story/0,2933,177884,00.html